Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
90.64
+3.43 (3.93%)
At close: May 20, 2026, 4:00 PM EDT
92.99
+2.35 (2.59%)
After-hours: May 20, 2026, 4:49 PM EDT
Rhythm Pharmaceuticals Employees
Rhythm Pharmaceuticals had 414 employees as of December 31, 2025. The number of employees increased by 131 or 46.29% compared to the previous year.
Employees
414
Change (1Y)
131
Growth (1Y)
46.29%
Revenue / Employee
$524,553
Profits / Employee
-$502,029
Market Cap
6.21B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 414 | 131 | 46.29% |
| Dec 31, 2024 | 283 | 57 | 25.22% |
| Dec 31, 2023 | 226 | 49 | 27.68% |
| Dec 31, 2022 | 177 | 37 | 26.43% |
| Dec 31, 2021 | 140 | 50 | 55.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Corcept Therapeutics | 730 |
| Mirum Pharmaceuticals | 418 |
| TG Therapeutics | 399 |
| Scholar Rock Holding | 289 |
| Apogee Therapeutics | 261 |
| Celcuity | 155 |
| CG Oncology | 142 |
RYTM News
- 6 days ago - Rhythm Pharmaceuticals Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 8 days ago - Rhythm Pharmaceuticals Announces New Data Presentations at the 2026 European Congress of Endocrinology - GlobeNewsWire
- 13 days ago - Rhythm Pharmaceuticals price target raised to $143 from $140 at Canaccord - TheFly
- 14 days ago - Rhythm Pharmaceuticals Announces Participation in Upcoming Bank of America Global Healthcare Conference - GlobeNewsWire
- 15 days ago - Rhythm Pharmaceuticals Earnings Call Transcript: Q1 2026 - Transcripts
- 15 days ago - Rhythm Pharmaceuticals Earnings release: Q1 2026 - Filings
- 15 days ago - Rhythm Pharmaceuticals Slides: Q1 2026 - Filings
- 15 days ago - Rhythm Pharmaceuticals Quarterly report: Q1 2026 - Filings